BEAM THERAPEUTICS INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$1.48B
↑+34.2% +$377Mvs FY2024
Total Liabilities
$243M
↓-34.4% -$127Mvs FY2024
Equity
$1.24B
↑+68.8% +$505Mvs FY2024
Cash
$295M
↑+4.6% +$13Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.48B | $1.10B |
| Current Assets | $1.27B | $878M |
| Cash | $295M | $282M |
| ST Investments | $950M | $569M |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $23M | $27M |
| Non-Current Assets | $212M | $226M |
| PPE | $105M | $111M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $108M | $114M |
| Total Liab+Eq | $1.48B | $1.10B |
| Current Liab. | $97M | $182M |
| Accounts Payable | $10M | $4M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $7M | $109M |
| Other CL | $80M | $69M |
| Non-Current Liab. | $146M | $188M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $146M | $188M |
| Equity | $1.24B | $734M |
| Retained Earnings | $1.64B | $1.57B |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · BEAM · Comparing FY2025 vs FY2024